Is your technology getting lost in a crowded market?
With around 2 million products registered for UK use, NHS commissioners are overwhelmed by choice. Without robust evidence, even the most promising technologies risk being overlooked.
A positive NICE evaluation sends a powerful signal to NHS commissioners, payers and international markets.
Want to know when NICE is evaluating healthtech in your field? Subscribe to NICE News and stay ahead of NICE’s healthtech priorities.